Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Phase II Trial of a Peptide Vaccine, Ocv-501 in Elderly Patients with Acute Myeloid Leukemia

Masaki Yamaguchi, MD PhD, Naoki Takezako, MD PhD, Toru Kiguchi, MD PhD, Shuichi Miyawaki, MD PhD, Yuji Heike, MD PhD, Kaori Mitsuki, Takahiro Yoshida, PhD, Ei Leen Liew, PhD MS, Tomoki Naoe, MD PhD

Blood (2018) 132 (Supplement 1): 29.

https://doi.org/10.1182/blood-2018-99-110013

Published: 2018

Journal Articles

A New Peptide Vaccine Ocv-501, Phase 1 Study in Patients with Acute Myeloid Leukemia and In Vitro Pharmacology

Tohru Sakura, MD, Yukio Kobayashi, MD PhD, Shuichi Miyawaki, MD PhD, Kazuyuki Toga, MS, Shinji Sogo, PhD, Yuji Heike, MD PhD

Blood (2016) 128 (22): 1643.

https://doi.org/10.1182/blood.V128.22.1643.1643

Published: 2016

Journal Articles

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Shigesaburo Miyakoshi, MD PhD, Kensuke Usuki, MD PhD, Itaru Matsumura, MD PhD, Yasunori Ueda, MD PhD, Hiromi Iwasaki, MD PhD, Toshihiro Miyamoto, MD PhD, Makoto Origuchi, Shuzo Tagashira, Ichiro Naoi, Tomoki Naoe, MD PhD, Masahiro Kizaki, MD PhD, Yuji Heike, MD PhD, Koichi Akashi, MD PhD, Yasushi Miyazaki, MD PhD

Blood (2016) 128 (22): 4335.

https://doi.org/10.1182/blood.V128.22.4335.4335

Published: 2016

Journal Articles

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Nobuhiro Hiramoto, MD, Kinuko Tajima, Saiko Kurosawa, MD, Takuya Yamashita, MD, Kenji Okinaka, MD, Noriyuki Morikawa, MD, Kohei Tada, MD, Takashi Tanaka, MD, Ryosuke Ueda, MD, Yujin Kobayashi, MD, Akihito Shinohara, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 2033.

https://doi.org/10.1182/blood.V118.21.2033.2033

Published: 2011

Journal Articles

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Ryuji Tanosaki, M.D., Tomoko Kumazawa, M.T., Shigehisa Yoshida, M.T., Atsuya Nakano, M.T., Shizuka Yamagata, M.T., Noriko Takahashi, M.T., Saiko Kurosawa, MD, Shin-Ichiro Mori, M.D., Yuji Heike, MD, Takahiro Fukuda, MD, Ko Furuta, M.D., Hitoshi Tsuda, M.D.

Blood (2011) 118 (21): 1922.

https://doi.org/10.1182/blood.V118.21.1922.1922

Published: 2011

Journal Articles

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Ryosuke Ueda, MD, Nobuhiro Hiramoto, MD, Shin-Ichiro Mori, MD, Saiko Kurosawa, MD, Takashi Tanaka, MD, Kohei Tada, MD, Yujin Kobayashi, MD, Noriyuki Morikawa, MD, Akihito Shinohara, MD, Keiji Okinaka, MD, Takuya Yamashita, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 4542.

https://doi.org/10.1182/blood.V118.21.4542.4542

Published: 2011

Journal Articles

Comparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar to FL

Kohei Tada, MD, Sung-Won Kim, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Kimikazu Yakushijin, MD, Saiko Kurosawa, MD, Niina Ueno, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Shinichiro Mori, MD, Yuji Heike, MD, Ryuji Tanosaki, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 3508.

https://doi.org/10.1182/blood.V116.21.3508.3508

Published: 2010

Journal Articles

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Takeshi Maeda, MD, Kimikazu Yakushijin, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Saiko Kurosawa, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Niina Ueno, MD, Sung-Won Kim, MD, Shin-Ichiro Mori, MD, Ryuji Tanosaki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 2318.

https://doi.org/10.1182/blood.V116.21.2318.2318

Published: 2010

Journal Articles

Evaluation of Potential role for Valproic Acid in IL-3-Mediated Megakaryopoiesis and Erythropoiesis in Serum-Free and Serum-Containing Cultures.

Kohshi Ohishi, MD, PhD, Bing Liu, Masahiro Masuya, Yuji Heike, MD, PhD, Yoichi Takaue, Naoyuki Katayama, MD, PhD

Blood (2009) 114 (22): 2746.

https://doi.org/10.1182/blood.V114.22.2746.2746

Published: 2009

Journal Articles

HDAC Inhibitors, FK228 and Valproic Acid, Enhance the Effects of IL-3 or GMCSF on the Generation of Early Megakaryocytic as Well as Erythroid Precursors from Human Hematopoietic Precursors

Kohshi Ohishi, MD, PhD, Hyou Ryuu, MD, Kentaro Yamamura, MD, PhD, Masahiro Masuya, MD, PhD, Yuji Heike, MD, PhD, Yoichi Takaue, MD, Naoyuki Katayama, MD, PhD

Blood (2008) 112 (11): 5397.

https://doi.org/10.1182/blood.V112.11.5397.5397

Published: 2008

Journal Articles

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Shigeo Fuji, MD, Sung-Won Kim, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Satoshi Yamasaki, MD, Yuriko Morita-Hoshi, MD, Fusako Ohara-Waki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1968.

https://doi.org/10.1182/blood.V110.11.1968.1968

Published: 2007

Journal Articles

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Bungo Saito, MD, Takahiro Fukuda, MD, Hiroki Yokoyama, MD, Saiko Kurosawa, MD, Toshihiro Takahashi, MD, Shigeo Fuji, MD, Noriko Takahashi, Kinuko Tajima, PhD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD, Yuji Heike, MD

Blood (2007) 110 (11): 2009.

https://doi.org/10.1182/blood.V110.11.2009.2009

Published: 2007

Journal Articles

Imaging the Differential Engraftment of GFP-Expressing Spleen and Bone Marrow Cells in Various Organs after Reduced-Intensity Stem Cell Transplantation in Mice Model.

Yuji Heike, MD, PhD, Zhijian Yang, PhD, Huaiyu Ma, PhD, Robert Hoffmann, PhD, Yuriko Morita, MD, Atsuko Soeda, MD, Hiroaki Makiyama, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2006) 108 (11): 3228.

https://doi.org/10.1182/blood.V108.11.3228.3228

Published: 2006

Journal Articles

A Retrospective Single Institute Analysis of 127 Lymphoma Patients Who Underwent Allogeneic Stem Cell Transplantation: Impact on Peripheral T-Cell Lymphoma (PTCL) Including ATLL.

Ryuji Tanosaki, MD, Sung-Won Kim, MD, Satoshi Yamazaki, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Yuji Heike, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2006) 108 (11): 3031.

https://doi.org/10.1182/blood.V108.11.3031.3031

Published: 2006

Journal Articles

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Eiji Usui, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2015.

https://doi.org/10.1182/blood.V106.11.2015.2015

Published: 2005

Journal Articles

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Ruri Kato, MD, Takahiro Fukuda, MD, Eiji Usui, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2731.

https://doi.org/10.1182/blood.V106.11.2731.2731

Published: 2005

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Dai Maruyama, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Eiji Usui, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 1142.

https://doi.org/10.1182/blood.V106.11.1142.1142

Published: 2005

Journal Articles

Divergent Roles of Histone Deacetylases in Human Adult Eythropoiesis.

Kohshi Ohishi, MD, Naoyuki Katayama, MD, Kentaro Yamamura, MD, Yuji Heike, MD, Yoichi Takaue, MD, Hiroshi Shiku, MD

Blood (2005) 106 (11): 130.

https://doi.org/10.1182/blood.V106.11.130.130

Published: 2005

Journal Articles

Analysis of Chimerism Induction Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Reduced-Intensity Regimen.

Rie Kojima, MD, Yuji Heike, MD, Jun Narumi, Shizuka Yamagata, Aki Chizuka, MD, Kisato Nosaka, MD, Masahiro Kami, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2004) 104 (11): 5027.

https://doi.org/10.1182/blood.V104.11.5027.5027

Published: 2004

Journal Articles

Synergistic Interaction between Notch ligand Delta-1 and IL-6/Soluble IL-6 Receptor Fusion Protein in the Generation of BFU-E from Primitive Hematopoietic Progenitors.

Kentaro Yamamura, MD, Kohshi Ohishi, MD, Naoyuki Katayama, MD, Hiroshi Shiku, MD, Masahiro Masuya, MD, Yuji Heike, MD, Mitsuo Nishikawa, MD, Tatsutoshi Nakahata, MD

Blood (2004) 104 (11): 1626.

https://doi.org/10.1182/blood.V104.11.1626.1626

Published: 2004

NARROW

Phase II Trial of a Peptide Vaccine, Ocv-501 in Elderly Patients with Acute Myeloid Leukemia

A New Peptide Vaccine Ocv-501, Phase 1 Study in Patients with Acute Myeloid Leukemia and In Vitro Pharmacology

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Comparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar to FL

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Evaluation of Potential role for Valproic Acid in IL-3-Mediated Megakaryopoiesis and Erythropoiesis in Serum-Free and Serum-Containing Cultures.

HDAC Inhibitors, FK228 and Valproic Acid, Enhance the Effects of IL-3 or GMCSF on the Generation of Early Megakaryocytic as Well as Erythroid Precursors from Human Hematopoietic Precursors

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Imaging the Differential Engraftment of GFP-Expressing Spleen and Bone Marrow Cells in Various Organs after Reduced-Intensity Stem Cell Transplantation in Mice Model.

A Retrospective Single Institute Analysis of 127 Lymphoma Patients Who Underwent Allogeneic Stem Cell Transplantation: Impact on Peripheral T-Cell Lymphoma (PTCL) Including ATLL.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Divergent Roles of Histone Deacetylases in Human Adult Eythropoiesis.

Analysis of Chimerism Induction Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Reduced-Intensity Regimen.

Synergistic Interaction between Notch ligand Delta-1 and IL-6/Soluble IL-6 Receptor Fusion Protein in the Generation of BFU-E from Primitive Hematopoietic Progenitors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only